Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...
But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.
For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.
1don MSN
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
News Medical on MSN1d
Smoking before age 15 significantly increases risk of chronic lung diseaseA study reveals childhood smoking significantly increases COPD risk in adulthood, highlighting the need for targeted ...
Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.
News Medical on MSN1d
Addressing COPD and metabolic syndrome requires comprehensive research effortsAdditional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
Boobalan Pachaiyappan, an analyst from Roth MKM, has initiated a new Buy rating on Verona Pharma (VRNA).Stay Ahead of the Market:Discover ...
HealthDay on MSN3d
Low Birth Weight May Increase Risk for Later COPDIndividuals in the lowest quintile of birth weight appear to have an increased risk for subsequent chronic obstructive ...
a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score-matched cohort study. The study included 20,388 propensity score-matched ...
GlobalData on MSN1d
AerWave Medical concludes study of ultrasound therapy for COPDThe study, involving five patients, demonstrated the procedural efficiency and feasibility of AerWave's technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback